The administration of caffeine has been developed as a chemical model
for the study of anxiety. However, previous researchers investigating
caffeine-induced anxiety states in humans have administered oral caffe
ine. In this dose-response study, we investigated the effects of blind
ly administered intravenous caffeine (3, 5, and 7 mg/kg) versus placeb
o in normal control subjects. We report the first series of subjects e
xperiencing olfactory hallucinations (10 of 10 subjects, 24 of 30 infu
sions) immediately following intravenous caffeine infusion. In additio
n, consistent with our previous work with oral caffeine, we found dose
-related increases in ratings of anxiety and blood levels of cortisol
and lactate. One subject experienced a DSM-III-R panic attack. Further
questioning revealed that his mother suffers panic attacks. Our findi
ngs of olfactory hallucinations are discussed within the context of lo
calized limbic system dysfunction, noting the phenomenologic and possi
ble neuroanatomic overlap between panic disorder and complex partial s
eizures. (C) 1995 Wiley-Liss, Inc.